InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024

By InvestorPlace Earnings

MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

INTS Stock Earnings: Intensity Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

INTS stock results show that Intensity Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

IOR Stock Earnings: Income Opportunity Realty Reported Results for Q2 2024

By InvestorPlace Earnings

Income Opportunity Realty just reported results for the second quarter of 2024.

NUTX Stock Earnings: Nutex Health Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

NUTX stock results show that Nutex Health missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

CYBN Stock Earnings: Cybin Beats EPS for Q1 2024

By InvestorPlace Earnings

CYBN stock results show that Cybin beat analyst estimates for earnings per share the first quarter of 2024.

Load More